|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taylor MD, Nagji AS, Bhamidipati CM,
Theodosakis N, Kozower BD, Lau CL and Jones DR: Tumor recurrence
after complete resection for non-small cell lung cancer. Ann Thorac
Surg. 93:1813–1821. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao Z, Zhu X and Dou Y: The miR-302/367
cluster: A comprehensive update on its evolution and functions.
Open Biol. 5:1501382015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barroso-del Jesus A, Lucena-Aguilar G and
Menendez P: The miR-302-367 cluster as a potential stemness
regulator in ESCs. Cell Cycle. 8:394–398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng X, Lu P and Fan Q: miR-367 promotes
proliferation and invasion of hepatocellular carcinoma cells by
negatively regulating PTEN. Biochem Biophys Res Commun.
470:187–191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaid C, Silva PBG, Cortez BA, Rodini CO,
Semedo-Kuriki P and Okamoto OK: miR-367 promotes proliferation and
stem-like traits in medulloblastoma cells. Cancer Sci.
106:1188–1195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu Z, Xu Y, Zhao J, Liu Q, Feng W, Fan J
and Wang P: miR-367 promotes epithelial-to-mesenchymal transition
and invasion of pancreatic ductal adenocarcinoma cells by targeting
the Smad7-TGF-β signalling pathway. Br J Cancer. 112:1367–1375.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bin Z, Dedong H, Xiangjie F, Hongwei X and
Qinghui Y: The microRNA-367 inhibits the invasion and metastasis of
gastric cancer by directly repressing Rab23. Genet Test Mol
Biomarkers. 19:69–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Campayo M, Navarro A, Viñolas N, Diaz T,
Tejero R, Gimferrer JM, Molins L, Cabanas ML, Ramirez J, Monzo M,
et al: Low miR-145 and high miR-367 are associated with
unfavourable prognosis in resected nonsmall cell lung cancer. Eur
Respir J. 41:1172–1178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akhoondi S, Sun D, von der Lehr N,
Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D,
Marth C, et al: FBXW7/hCDC4 is a general tumor suppressor in
human cancer. Cancer Res. 67:9006–9012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Guo Y, Liang X, Sun M, Wang G, De W
and Wu W: MicroRNA-223 functions as an oncogene in human gastric
cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol.
138:763–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gong J, Cui Z, Li L, Ma Q, Wang Q, Gao Y
and Sun H: MicroRNA-25 promotes gastric cancer proliferation,
invasion, and migration by directly targeting F-box and WD-40
Domain Protein 7, FBXW7. Tumour Biol. 36:7831–7840. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren H, Koo J, Guan B, Yue P, Deng X, Chen
M, Khuri FR and Sun SY: The E3 ubiquitin ligases β-TrCP and FBXW7
cooperatively mediates GSK3-dependent Mcl-1 degradation induced by
the Akt inhibitor API-1, resulting in apoptosis. Mol Cancer.
12:1462013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun X, Tang SC, Xu C, Wang C, Qin S, Du N,
Liu J, Zhang Y, Li X, Luo G, et al: DICER1 regulated let-7
expression levels in p53-induced cancer repression requires cyclin
D1. J Cell Mol Med. 19:1357–1365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiang BU and Jiang H: Chemosensitivity
testing for human prostatic cancer with primary culture cells and
purified culture cells using the CCK-8 assay. Pharmaceutical and
Clinical Research. 2013.
|
|
16
|
Wang GC, He QY, Tong DK, Wang CF, Liu K,
Ding C, Ji F and Zhang H: MiR-367 negatively regulates apoptosis
induced by adriamycin in osteosarcoma cells by targeting KLF4. J
Bone Oncol. 5:51–56. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui
R and Wang Y: High miR-196a and low miR-367 cooperatively correlate
with unfavorable prognosis of high-grade glioma. Int J Clin Exp
Pathol. 8:6576–6588. 2015.PubMed/NCBI
|
|
18
|
Zhang L, Liu Y, Song F, Zheng H, Hu L, Lu
H, Liu P, Hao X, Zhang W and Chen K: Functional SNP in the
microRNA-367 binding site in the 3′UTR of the calcium channel
ryanodine receptor gene 3 (RYR3) affects breast cancer risk
and calcification. Proc Natl Acad Sci USA. 108:13653–13658. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun J, Song K, Feng X and Gao S:
MicroRNA-367 is a potential diagnostic biomarker for patients with
esophageal squamous cell carcinoma. Biochem Biophys Res Commun.
473:363–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hanahan D and Awada A: The Hallmarks of
Cancer Review. Ann Oncol. 100:57–70. 2012.
|
|
21
|
Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng
X and Tu K: MicroRNA-92a contributes to tumor growth of human
hepatocellular carcinoma by targeting FBXW7. Oncol Rep.
34:2576–2584. 2015.PubMed/NCBI
|
|
22
|
Guo Z, Zhou Y, Evers BM and Wang Q: Rictor
regulates FBXW7-dependent c-Myc and cyclin E degradation in
colorectal cancer cells. Biochem Biophys Res Commun. 418:426–432.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu Y, Lin Y, Yang Z, Yang G, Li G, Liu Y,
Tan X, Huang Y, Wu X, Wang Y, et al: FBXW7 overexpression
suppresses renal cancer cell proliferation and induces apoptosis.
Med Oncol. 32:2152015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen J: Mechanism of molecular regulation
of cyclin E-CDK2. Journal of Medical Molecular Biology. 2006.
|
|
25
|
Schwabe RF, Bradham CA, Uehara T, Hatano
E, Bennett BL, Schoonhoven R and Brenner DA: c-Jun-N-terminal
kinase drives cyclin D1 expression and proliferation during liver
regeneration. Hepatology. 37:824–832. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Anokye-Danso F, Trivedi CM, Juhr D, Gupta
M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, et al:
Highly efficient miRNA-mediated reprogramming of mouse and human
somatic cells to pluripotency. Cell Stem Cell. 8:376–388. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin SL, Chang DC, Lin CH, Ying SY, Leu D
and Wu DT: Regulation of somatic cell reprogramming through
inducible mir-302 expression. Nucleic Acids Res. 39:1054–1065.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang H, Lu X, Liu Z, Chen L, Xu Y, Wang Y,
Wei G and Chen Y: FBXW7 suppresses epithelial-mesenchymal
transition, stemness and metastatic potential of cholangiocarcinoma
cells. Oncotarget. 6:6310–6325. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Liu Y, Lu J, Zhang P, Wang Y, Xu
Y, Wang Z, Mao JH and Wei G: Rapamycin inhibits FBXW7 loss-induced
epithelial-mesenchymal transition and cancer stem cell-like
characteristics in colorectal cancer cells. Biochem Biophys Res
Commun. 434:352–356. 2013. View Article : Google Scholar : PubMed/NCBI
|
